Covid-19 All Centre Update for w/c 25th May 2020
To help UK NEQAS participants in the current Covid-19 (Coronavirus) outbreak, we will be providing a weekly all-centre update. We will also provide an email address for each centre should anyone wish to make direct contact with their centre. Here’s the update for week commencing 25th May 2020:
|UK NEQAS Centre||Update for w/c 25th May 2020|
|Birmingham Quality (Clinical Chemistry)||Birmingham Quality will be open as usual this week and the on-line Schedule remains valid. Because of the Bank Holiday, no regular postal dispatches are planned as is our regular practice. - email: firstname.lastname@example.org|
|Blood Coagulation||email: email@example.com|
|Blood Transfusion Laboratory Practice||email: firstname.lastname@example.org|
|Cardiac Markers||Operating as normal. Distribution 265 for June will be back to scheduled distribution date - email: email@example.com
Information can be found on the UK NEQAS Cardiac Markers website www.ukneqas-cm.org.uk.
|Cellular Pathology Technique||At the end of March UK NEQAS CPT took the decision to postpone all Educational Workshops until 1st June 2020, due to the Covid-19 situation in the UK and across the world. Delegates were provided with an alterative date to attend in the latter part of the year.
As our next programme of Educational Workshops is due to begin in the next few weeks, and we are unsure how this will look until we have more information, we feel we have been left with no alternative but to postpone our Educational Workshops through June.
To continue our commitment to education and training, we recently launched "CPTCast" on Twitter and LinkedIn; consisting of daily posts to continually reinforce that even during these extraordinary times; Quality Matters.
In addition to this, we are launching a series of webinars, whilst we amend our programme to ensure continued UK NEQAS CPT educational support and delivery. The UK NEQAS CPT Educational Webinars will be free of charge, and will be available to all participants.
- email: firstname.lastname@example.org
|Edinburgh Peptide Hormones||email: email@example.com|
|Genomics (GenQA)||GenQA are committed to supporting genomics laboratories in meeting their EQA requirements for the 2020-21 season.
We have updated the EQA programmeEQA programme to reduce the genomics laboratory workload, whilst ensuring EQA coverage of the breadth of technologies within laboratories. These changes include:
- Rescheduling EQA distributions to take place later in the year (between July 2020 and January 2021).
- Revising the format of some EQAs to:
o focus on providing EQAs for core tests
o provide fewer samples for laboratory testing
o minimise the testing required (e.g. single variant only)
o change EQAs to interpretation only (e.g. no laboratory testing required)
o change EQAs to genotyping only (where laboratory testing is required)
o merge EQAs where appropriate
o postpone a small number of EQAs to the 2021-22 season
- Reduce EQA fees, for some EQAs, to reflect the changes implemented.
For the revised timetable and fees of all EQAs for 2020-21, please download the: Revised EQA timetable - May 2020
For our latest news on COVID-19 please go to: www.genqa.org/covid19.
Due to the COVID-19 pandemic, contact by telephone may not be possible therefore please email firstname.lastname@example.org.
Thank you for your continued support.
|Guildford Peptide Hormones||UK NEQAS Guildford Peptides arenoperating a normal service - email: email@example.com|
|Haematology||UK NEQAS Haematology is open as usual but operating to a slightly amended schedule for June, as published on our website. Some reports have been delayed as we have allowed participants as much time as possible to return their results.
There will be no LN specimens supplied with the June Abnormal Haemoglobins distribution 2003AH because of survey material supply disruption related to the Covid-19 pandemic.
We would be grateful if participants could continue to email firstname.lastname@example.org rather than phone, where possible.
|Head and Neck Pathology||email: email@example.com|
|Histocompatibility & Immunogenetics||H&I will be releasing the first shipment of samples for the 2020-21 distribution year on the 2nd June - email: firstname.lastname@example.org|
|Immunocytochemistry & In-Situ Hybridisation||As announced some time ago, we continue on track to deliver the next EQA run, with an expected despatch date 3rd week in June. Previous EQA run PD-L1 assessment was held over as it requires very specialist external assistance which has now been arranged. This module will be assess and reported over the next two weeks - email: email@example.com|
|Immunology, Immunochemistry & Allergy||IIA will be preparing and sending out the Covid-19 Antibody Pilot EQA samples to all participating laboratories - email: firstname.lastname@example.org|
|Leucocyte Immunophenotyping||No change, running all services as planned but with home working where possible and limited staff on site - email: email@example.com|
|Parasitology||Parasitology is planning to resume distributions, starting in the first week of July 2020 - email: firstname.lastname@example.org|
|Reproductive Science||Distribution 105 is now open. Due to the Covid-19 pandemic, Reproductive Science have extended the deadline for Distribution 105 by an extra four weeks to Monday 29th June, although participants are urged to complete the assessment as soon as they are able to do so - email: email@example.com|
|Trace Elements||UK NEQAS Trace Elements are operating a normal service - email: firstname.lastname@example.org|
|UK National BNS Neuropathology Interpretative EQA Scheme||email: email@example.com|
|Vitamin K||Running as normal - email: firstname.lastname@example.org|